DMD and Cognitive impairment: Mutations in the first exons that selectively affect expression of Dp427 lead to moderate cognitive deficits, whereas in about one-third of patients downstream mutations inducing a cumulative loss of the shorter dystrophin products are responsible for moderate to severe intellectual disability (Desguerre et al., 2009).